FinTrust Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
FinTrust Capital Advisors's PFE Position: Q3 2024 in Review
FinTrust Capital Advisors increased its Pfizer (PFE) stake by 4.6% in Q3 2024, buying an estimated $41.2K and bringing the position to 32,415 shares worth $938K. The position accounts for 0.16% of the portfolio, ranked #121.
FinTrust Capital Advisors first reported a position in PFE in Q4 2018 and has held it in 24 quarters since. The position peaked at $2.2M in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- FinTrust Capital Advisors held 32,415 shares of Pfizer worth $938K as of Q3 2024.
- FinTrust Capital Advisors bought 1,413 Pfizer shares in Q3 2024, an estimated $41.2K.
- Pfizer made up 0.16% of FinTrust Capital Advisors's portfolio in Q3 2024, its #121 holding.
- FinTrust Capital Advisors first reported a position in Pfizer in Q4 2018 and has held it in 24 quarters since.
- FinTrust Capital Advisors's Pfizer position peaked at $2.2M in Q4 2021.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.